NO983669L - Coralyne analoger som topoisomeraseinhibitorer - Google Patents
Coralyne analoger som topoisomeraseinhibitorerInfo
- Publication number
- NO983669L NO983669L NO983669A NO983669A NO983669L NO 983669 L NO983669 L NO 983669L NO 983669 A NO983669 A NO 983669A NO 983669 A NO983669 A NO 983669A NO 983669 L NO983669 L NO 983669L
- Authority
- NO
- Norway
- Prior art keywords
- topoisomerase inhibitors
- derivatives
- coralyne
- analogues
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1145296P | 1996-02-12 | 1996-02-12 | |
| US3216196P | 1996-10-01 | 1996-10-01 | |
| PCT/US1997/001676 WO1997029106A1 (en) | 1996-02-12 | 1997-02-11 | Coralyne analogs as topoisomerase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983669D0 NO983669D0 (no) | 1998-08-11 |
| NO983669L true NO983669L (no) | 1998-09-23 |
Family
ID=26682407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983669A NO983669L (no) | 1996-02-12 | 1998-08-11 | Coralyne analoger som topoisomeraseinhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0888346B1 (pt) |
| JP (1) | JP2000504687A (pt) |
| KR (1) | KR19990082488A (pt) |
| CN (1) | CN1067070C (pt) |
| AU (1) | AU710070C (pt) |
| BR (1) | BR9707425A (pt) |
| CA (1) | CA2241551A1 (pt) |
| CZ (1) | CZ254498A3 (pt) |
| DE (1) | DE69705112T2 (pt) |
| ES (1) | ES2161442T3 (pt) |
| HU (1) | HUP9900413A3 (pt) |
| IL (1) | IL124803A0 (pt) |
| NO (1) | NO983669L (pt) |
| NZ (1) | NZ330705A (pt) |
| PL (1) | PL328402A1 (pt) |
| PT (1) | PT888346E (pt) |
| TR (1) | TR199801555T2 (pt) |
| WO (1) | WO1997029106A1 (pt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW460464B (en) * | 1996-11-25 | 2001-10-21 | Nippon Kayaku Kk | Novel phenanthridinium derivative having an anti-tumor activity and pharmaceutical composition containing the same |
| US6140328A (en) | 1997-12-12 | 2000-10-31 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
| IL137351A0 (en) | 1998-02-12 | 2001-07-24 | Univ Rutgers | Heterocyclic topoisomerase poisons |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| CN1093129C (zh) * | 1999-08-19 | 2002-10-23 | 广州市海科生物技术有限公司 | 一种具有抗肿瘤生理活性的尖叶唐松草阿原碱及其提取方法 |
| US6740650B2 (en) | 1999-10-29 | 2004-05-25 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
| SI1465625T1 (sl) | 2001-11-14 | 2010-06-30 | Univ Rutgers | Solubilizirani topoizomerazni strupi |
| WO2003051289A2 (en) | 2001-11-14 | 2003-06-26 | Rutgers, The State University | Solubilized topoisomerase poison agents |
| AU2002364953A1 (en) | 2001-11-14 | 2003-06-17 | Edmond J. Lavoie | Topoisomerase poison agents |
| AU2003268075A1 (en) | 2002-08-09 | 2004-02-25 | Edmond J. Lavoie | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
| AU2003265406A1 (en) | 2002-08-09 | 2004-02-25 | Edmond J. Lavoie | Nitro and amino substituted topoisomerase agents |
| WO2004014862A1 (en) | 2002-08-09 | 2004-02-19 | Rutgers, The State University | Nitro and amino substituted heterocycles as topoisomerase i targeting agents |
| AU2003290818A1 (en) | 2002-11-12 | 2004-06-03 | Edmond J. Lavoie | Topoisomerase-targeting agents |
| CN101365446B (zh) | 2005-07-29 | 2013-05-22 | 雷斯弗洛吉克斯公司 | 预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送 |
| JP5236664B2 (ja) | 2007-02-01 | 2013-07-17 | レスバーロジックス コーポレイション | 心血管疾患を予防および治療するための化合物 |
| EP2014651A1 (en) * | 2007-07-12 | 2009-01-14 | Exonhit Therapeutics SA | Compounds and methods for modulating Rho GTPases |
| AU2009262252B2 (en) | 2008-06-26 | 2013-05-02 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
| CA2747417C (en) | 2009-01-08 | 2017-01-03 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| WO2010102219A1 (en) | 2009-03-06 | 2010-09-10 | Rutgers, The State University Of New Jersey | Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer |
| NZ708314A (en) | 2009-03-18 | 2017-08-25 | Resverlogix Corp | Quinazolinones for use as anticancer agents |
| BRPI1014956B8 (pt) | 2009-04-22 | 2021-05-25 | Resverlogix Corp | agentes anti-inflamatórios |
| WO2010127363A1 (en) | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
| US8188109B2 (en) * | 2009-07-20 | 2012-05-29 | Naxospharma S.R.L. | Benzoquinolizinium salt derivatives as anticancer agents |
| CN102746292B (zh) * | 2011-04-18 | 2015-03-18 | 中国医学科学院医药生物技术研究所 | 环化的小檗碱衍生物及其制备方法和用途 |
| CA2851996C (en) | 2011-11-01 | 2020-01-07 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| MX2015007921A (es) | 2012-12-21 | 2016-03-03 | Zenith Epigenetics Corp | Compuestos heterociclicos novedosos como inhibidores de bromodominio. |
| WO2014144097A1 (en) * | 2013-03-15 | 2014-09-18 | Georgetown University | Antifungal drugs |
| CN105682661B (zh) | 2013-08-23 | 2020-03-27 | 润新生物公司 | 某些化学实体、组合物和方法 |
| CA2976227C (en) * | 2015-02-17 | 2023-10-24 | Neupharma, Inc. | Quinazoline derivatives and their use in treatment of cancer |
| JP6903585B2 (ja) | 2015-03-13 | 2021-07-14 | レスバーロジックス コーポレイション | 補体関連疾患の治療のための組成物および治療方法 |
| CN105541714A (zh) * | 2015-12-16 | 2016-05-04 | 浙江普洛康裕制药有限公司 | 一种罂粟碱及盐酸罂粟碱的制备方法 |
| WO2017176648A1 (en) | 2016-04-04 | 2017-10-12 | Rutgers, The State University Of New Jersey | Topoisomerase poisons |
| EP4006035B1 (en) | 2016-08-15 | 2023-11-22 | Neupharma, Inc. | Quinazoline derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| CN110759963A (zh) * | 2018-07-25 | 2020-02-07 | 中山大学 | 一种稠环类化合物及其制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126351A (en) * | 1991-01-24 | 1992-06-30 | Glaxo Inc. | Antitumor compounds |
| US5223506A (en) * | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
-
1997
- 1997-02-11 KR KR1019980706221A patent/KR19990082488A/ko not_active Application Discontinuation
- 1997-02-11 BR BR9707425A patent/BR9707425A/pt unknown
- 1997-02-11 PL PL97328402A patent/PL328402A1/xx unknown
- 1997-02-11 JP JP9528606A patent/JP2000504687A/ja active Pending
- 1997-02-11 ES ES97906466T patent/ES2161442T3/es not_active Expired - Lifetime
- 1997-02-11 IL IL12480397A patent/IL124803A0/xx unknown
- 1997-02-11 EP EP97906466A patent/EP0888346B1/en not_active Expired - Lifetime
- 1997-02-11 CA CA002241551A patent/CA2241551A1/en not_active Abandoned
- 1997-02-11 PT PT97906466T patent/PT888346E/pt unknown
- 1997-02-11 CZ CZ982544A patent/CZ254498A3/cs unknown
- 1997-02-11 HU HU9900413A patent/HUP9900413A3/hu unknown
- 1997-02-11 NZ NZ330705A patent/NZ330705A/en unknown
- 1997-02-11 CN CN97192211A patent/CN1067070C/zh not_active Expired - Fee Related
- 1997-02-11 TR TR1998/01555T patent/TR199801555T2/xx unknown
- 1997-02-11 DE DE69705112T patent/DE69705112T2/de not_active Expired - Fee Related
- 1997-02-11 AU AU21155/97A patent/AU710070C/en not_active Ceased
- 1997-02-11 WO PCT/US1997/001676 patent/WO1997029106A1/en not_active Application Discontinuation
-
1998
- 1998-08-11 NO NO983669A patent/NO983669L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ254498A3 (cs) | 1998-12-16 |
| ES2161442T3 (es) | 2001-12-01 |
| JP2000504687A (ja) | 2000-04-18 |
| DE69705112D1 (en) | 2001-07-12 |
| CA2241551A1 (en) | 1997-08-14 |
| AU2115597A (en) | 1997-08-28 |
| AU710070B2 (en) | 1999-09-16 |
| BR9707425A (pt) | 1999-07-20 |
| WO1997029106A1 (en) | 1997-08-14 |
| EP0888346A1 (en) | 1999-01-07 |
| EP0888346B1 (en) | 2001-06-06 |
| KR19990082488A (ko) | 1999-11-25 |
| PL328402A1 (en) | 1999-01-18 |
| TR199801555T2 (xx) | 1998-11-23 |
| CN1067070C (zh) | 2001-06-13 |
| PT888346E (pt) | 2001-10-31 |
| DE69705112T2 (de) | 2002-03-21 |
| CN1211252A (zh) | 1999-03-17 |
| AU710070C (en) | 2001-08-30 |
| IL124803A0 (en) | 1999-01-26 |
| NZ330705A (en) | 2000-03-27 |
| NO983669D0 (no) | 1998-08-11 |
| HUP9900413A2 (hu) | 1999-05-28 |
| HUP9900413A3 (en) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983669L (no) | Coralyne analoger som topoisomeraseinhibitorer | |
| EP1017675A4 (en) | HIGHLY LIPOPHILIC CAMPTOTHECIN DERIVATIVES | |
| AU2592600A (en) | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | |
| NO993654L (no) | Kit for Õ inhibere cancervekst, omfattende et kjemoterapeutisk middel og et benzimidazol og eventuelt en forsterker | |
| HK1084602A1 (en) | Tricyclic parp inhibitors | |
| MX9307011A (es) | Derivados hidrosolubles de camptotecina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| AU2001273983A1 (en) | Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo(3,2-e)indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo(f)quinoline derivatives for use in selective cancer therapy | |
| AU3217097A (en) | Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents | |
| MY133016A (en) | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate | |
| MY136610A (en) | Combined preparations comprising morpholine anthracyclines and platinum derivatives | |
| MX9800408A (es) | Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
| AU6797298A (en) | Halo-alkoxycarbonyl prodrugs | |
| DE69321254D1 (de) | Quinuclidin derivate als squalene synthase inhibitoren | |
| WO2002072021A3 (en) | Agents and methods for the prevention of initial onset and recurrence of existing cancers | |
| MX9304355A (es) | Compuestos heterociclicos. | |
| MY134690A (en) | Antitumor therapy comprising distamycin derivatives. | |
| AU2001291133A1 (en) | Methods of decreasing or preventing pain using spicamycin derivatives | |
| DE69902748D1 (de) | Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie | |
| HUP0002717A2 (hu) | 13-Dezoxiantraciklin-származékok és előállítási eljárásaik | |
| HK1041648A1 (en) | Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof | |
| IT1313593B1 (it) | Derivati di 1,2-diidro-1-oxo-pirazino 1,2-a indolo. | |
| WO2001070093A3 (en) | Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers | |
| AU4344202A (en) | Indolocarbazole anticancer agents and methods of using them | |
| DE60030754D1 (de) | Potenzierung der wirksamkeit von sn-38-prodrogen | |
| UA36385A (uk) | Спосіб лікування генералізованого пародонтиту |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |